Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma-Reference-Cited by-同舟云学术

Dysregulation of lipidomic profile and antiviral immunity in response to hyaluronan in patients with severe asthma

Published:2017-04 Issue:4 Volume:139 Page:1379-1383
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Sokolowska Milena,Chen Li-Yuan,Liu Yueqin,Martinez-Anton Asuncion,Logun Carolea,Alsaaty Sara,Cuento Rosemarie A.,Cai Rongman,Sun Junfeng,Quehenberger Oswald,Armando Aaron M.,Dennis Edward A.,Levine Stewart J.,Shelhamer James H.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference10 articles.

1. Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program;Jarjour;Am J Respir Crit Care Med,2012

2. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons;Gielen;J Allergy Clin Immunol,2015

3. Hyaluronan and its heavy chain modification in asthma severity and experimental asthma exacerbation;Lauer;J Biol Chem,2015

4. Role of hyaluronan and hyaluronan-binding proteins in human asthma;Liang;J Allergy Clin Immunol,2011

5. Low molecular weight hyaluronan activates cytosolic phospholipase A2 alpha and eicosanoid production in monocytes and macrophages;Sokolowska;J Biol Chem,2014

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific microRNA Profile Associated with Inflammation and Lipid Metabolism for Stratifying Allergic Asthma Severity;International Journal of Molecular Sciences;2024-08-30

2. L-Phenylalanine is a metabolic checkpoint of human Th2 cells;2024-07-29

3. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks;Cell Cycle;2024-02-16

4. Network-based analysis between SARS-CoV-2 receptor ACE2 and common host factors in COVID-19 and asthma: Potential mechanistic insights;Biomedical Signal Processing and Control;2024-01

5. Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology;Allergy;2023-12-18